Outsourced Pharma Webinars

  1. Mobilizing Science, Partnership, And Capability To Develop A Gene Therapy In 14 Months 9/17/2025

    Hear how one family, driven by urgency, partnered with AAV experts to develop a treatment for their daughter’s ultra-rare neurodegenerative disorder, NEDAMSS, in just 14 months.

  2. Nanoforming Biologics, GLP-1s: From I.V. To Sub Q And Inhaled Delivery 9/9/2025

    Nanoforming enables new delivery routes for biologics and peptides to simplify dosing, enhance patient comfort, and reduce healthcare costs.

  3. Managing Endotoxins - Detect, Prevent, Remove 9/8/2025

    Explore the risks of endotoxin contamination in drug manufacturing and discover sustainable, animal-free detection methods to ensure pharmaceutical safety and regulatory compliance.

  4. Benefits Of Outsourcing To An Integrated CDMO 9/8/2025

    Streamlining ADC development through an integrated CDMO can reduce risk and improve quality. Discover why specialized expertise in linker chemistry and bioconjugation is key to overcoming the complexity of ADC manufacturing.

  5. Extractables, Leachables, And Risk: Ensuring Safety In Pharma Manufacturing 9/8/2025

    This session is designed for teams developing new products, optimizing processes, or preparing regulatory submissions, and will provide practical tools for a better approach to E&L management.

  6. Solving Fragmentation: Future-Proofing The Advanced Therapy Supply Chain 9/5/2025

    Whether you are preparing for your first clinical shipment or scaling for global distribution, this conversation provides strategies to streamline operations, improve reliability, and deliver better patient outcomes.

  7. Strategic Approaches To Controlled Release Formulation: Polymer Screening And Case Study Insights 9/4/2025

    Discover how early polymer selection drives formulation success, with case studies linking polymer choice to drug release and practical insights for developing robust CR products.

  8. Building Quality By Design For Multi-Specific Therapeutic Proteins 9/2/2025

    Platforms incorporating high throughput in silico screening, in vitro expression, and immunosafety of multi-specific molecules can help mitigate potential developability risks and accelerate timelines.

  9. N-1 Perfusion Strategies For Commercial-Ready Biologics 8/27/2025

    Learn how an approach with modular N-1 perfusion strategies shortens seed train timelines and reduces facility strain — enabling upstream processes that scale efficiently and reliably for commercial manufacturing.

  10. Overcoming Challenges In Ophthalmic Formulations 8/27/2025

    Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.